Tom 13, Nr 2 (2018)
NIEWYDOLNOŚĆ SERCA
Opublikowany online: 2018-05-30

dostęp otwarty

Wyświetlenia strony 444
Wyświetlenia/pobrania artykułu 1847
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

Infekcyjne zapalenie mięśnia sercowego a szerokość geograficzna

Weronika Malinkiewicz, Agnieszka Pawlak
Kardiol Inwazyjna 2018;13(2):14-22.

Streszczenie

Zapalenie mięśnia sercowego jest jednostką chorobową szeroko rozpowszechnioną na całym świecie. Jedną z najczęstszych przyczyn jej występowania są wirusy kardiotropowe, takie jak: enterowirusy, adenowirusy, parwowirus B19 czy wirus opryszczki ludzkiej typu 6, a także rzadziej obecne wirusy cytomegalii, Epsteina-Barr, wirus świnki czy wirus zapalenia wątroby typu C. Procentowy udział wirusów w patogenezie infekcyjnego zapalenia mięśnia sercowego jest jednak różny w zależności od badanej populacji. W niektórych regionach świata jako przyczynę zapalenia odnotowuje się też częste występowanie etiologii pasożytniczej lub pierwotniakowej (Toxoplasma gondii, Trypanosoma cruzi). W niniejszej pracy została podjęta próba zestawienia danych epidemiologicznych na temat najczęściej odnotowywanych czynników infekcyjnych zapalenia mięśnia sercowego, w krajach o różnej szerokości geograficznej (Niemcy, Polska, Włochy, Finlandia, Stany Zjednoczone, Meksyk, Brazylia, kraje Afryki Subsaharyjskiej).

Artykuł dostępny w formacie PDF

Pokaż PDF Pobierz plik PDF

Referencje

  1. Caforio ALP, Pankuweit S, Arbustini E, et al. European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013; 34(33): 2636–48, 2648a.
  2. Schultz JC, Hilliard AA, Cooper LT, et al. Diagnosis and treatment of viral myocarditis. Mayo Clin Proc. 2009; 84(11): 1001–1009.
  3. Broliden K, Tolfvenstam T, Norbeck O. Clinical aspects of parvovirus B19 infection. J Intern Med. 2006; 260(4): 285–304.
  4. Cohen B. Parvovirus B19: an expanding spectrum of disease. BMJ. 1995; 311(7019): 1549–1552.
  5. Bültmann BD, Klingel K, Sotlar K, et al. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol. 2003; 34(1): 92–95.
  6. Yoshikawa T, Ihira M, Suzuki K, et al. Fatal acute myocarditis in an infant with human herpesvirus 6 infection. J Clin Pathol. 2001; 54(10): 792–795.
  7. Kim KS. The Primary Viruses of Myocarditis. In: Cooper LT. ed. Myocarditis: From Bench to Bedside. Humana Press, Totowa, NJ 2003: 23–53.
  8. Matsumori A. Hepatitis C virus infection and cardiomyopathies. Circ Res. 2005; 96(2): 144–147.
  9. Kühl U, Pauschinger M, Bock T, et al. Parvovirus B19 infection mimicking acute myocardial infarction. Circulation. 2003; 108(8): 945–950.
  10. Kühl U, Pauschinger M, Seeberg B, et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation. 2005; 112(13): 1965–1970.
  11. Klein RM, Jiang H, Niederacher D, et al. Frequency and quantity of the parvovirus B19 genome in endomyocardial biopsies from patients with suspected myocarditis or idiopathic left ventricular dysfunction. Z Kardiol. 2004; 93(4): 300–309.
  12. Mahrholdt H, Wagner A, Deluigi CC, et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation. 2006; 114(15): 1581–1590.
  13. Yilmaz A, Mahrholdt H, Athanasiadis A, et al. Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis. Heart. 2008; 94(11): 1456–1463.
  14. Tschöpe C, Bock CT, Kasner M, et al. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation. 2005; 111(7): 879–886.
  15. Nielsen TS, Hansen J, Nielsen LP, et al. The presence of enterovirus, adenovirus, and parvovirus B19 in myocardial tissue samples from autopsies: an evaluation of their frequencies in deceased individuals with myocarditis and in non-inflamed control hearts. Forensic Sci Med Pathol. 2014; 10(3): 344–350.
  16. Kühl U, Pauschinger M, Noutsias M, et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation. 2005; 111(7): 887–893.
  17. Hufnagel G, Pankuweit S, Richter A, et al. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz. 2000; 25(3): 279–285.
  18. Pauschinger M, Bowles NE, Fuentes-Garcia FJ, et al. Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation. 1999; 99(10): 1348–1354.
  19. Pauschinger M, Phan MD, Doerner A, et al. Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation. 1999; 99(7): 889–895.
  20. Donoso Mantke O, Meyer R, Prösch S, et al. High prevalence of cardiotropic viruses in myocardial tissue from explanted hearts of heart transplant recipients and heart donors: a 3-year retrospective study from a German patients' pool. J Heart Lung Transplant. 2005; 24(10): 1632–1638.
  21. Pawlak A, Przybylski M, Durlik M, et al. Viral Nucleic Acids in the Serum Are Dependent on Blood Sampling Site in Patients with Clinical Suspicion of Myocarditis. Intervirology. 2016; 59(3): 143–151.
  22. Giacca M, Severini G, Mestroni L, et al. Low frequency of detection by nested polymerase chain reaction of enterovirus ribonucleic acid in endomyocardial tissue of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1994; 24(4): 1033–1040.
  23. Angelini A, Crosato M, Boffa GM, et al. Active versus borderline myocarditis: clinicopathological correlates and prognostic implications. Heart. 2002; 87(3): 210–215.
  24. Calabrese F, Rigo E, Milanesi O, et al. Molecular diagnosis of myocarditis and dilated cardiomyopathy in children: clinicopathologic features and prognostic implications. Diagn Mol Pathol. 2002; 11(4): 212–221.
  25. Caforio ALP, Calabrese F, Angelini A, et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J. 2007; 28(11): 1326–1333.
  26. Calabrese F, Valente M, Thiene G, et al. Enteroviral Genome in Native Hearts May Influence Outcome of Patients Who Undergo Cardiac Transplantation. Diagn Mol Pathol. 1999; 8(1): 39–46.
  27. Angelini A, Calzolari V, Calabrese F, et al. Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis. Heart. 2000; 84(3): 245–250.
  28. Kytö V, Vuorinen T, Saukko P, et al. Cytomegalovirus infection of the heart is common in patients with fatal myocarditis. Clin Infect Dis. 2005; 40(5): 683–688.
  29. Griffin L, Kearney D, Ni J, et al. Analysis of formalin-fixed and frozen myocardial autopsy samples for viral genome in childhood myocarditis and dilated cardiomyopathy with endocardial fibroelastosis using polymerase chain reaction (PCR). Cardiovascular Pathol. 1995; 4(1): 3–11.
  30. Bowles NE, Ni J, Kearney DL, et al. Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol. 2003; 42(3): 466–472.
  31. Guillén-Ortega F, Soto ME, Reyes PA. [Primary acute myocarditis. A 10- years institutional experience]. Arch Cardiol Mex. 2005; 75(Suppl 3): 81–88.
  32. Ferreira Júnior AG, Ferreira SM, Gomes ML, et al. Enteroviruses as a possible cause of myocarditis, pericarditis and dilated cardiomyopathy in Belém, Brazil. Braz J Med Biol Res. 1995; 28(8): 869–874.
  33. Mahfoud F, Gärtner B, Kindermann M, et al. Virus serology in patients with suspected myocarditis: utility or futility? Eur Heart J. 2011; 32(7): 897–903.
  34. Falase AO. Infections and dilated cardiomyopathy in Nigeria. Heart Vessels Suppl. 1985; 1: 40–44.
  35. Blackett K, Ngu JL. Immunological studies in congestive cardiomyopathy in Cameroon. Br Heart J. 1976; 38(6): 605–611.
  36. Sanderson JE, Olsen EG, Gatei D. Dilated cardiomyopathy and myocarditis in Kenya: an endomyocardial biopsy study. Int J Cardiol. 1993; 41(2): 157–163.
  37. Okonko IO, Adebiyi AA, Ogah OS, et al. Enteroviruses as a possible cause of hypertension, dilated cardiomyopathy (DCM) and hypertensive heart failure (HHF) in South western Nigeria. Afr Health Sci. 2013; 13(4): 1098–1106.
  38. Gaaloul I, Riabi S, Harrath R, et al. Coxsackievirus B detection in cases of myocarditis, myopericarditis, pericarditis and dilated cardiomyopathy in hospitalized patients. Mol Med Rep. 2014; 10(6): 2811–2818.